This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05514548
Recruitment Status : Recruiting
First Posted : August 24, 2022
Last Update Posted : February 12, 2024
Worldwide Clinical Trials
Information provided by (Responsible Party):
Inversago Pharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 3, 2024
Estimated Study Completion Date : September 24, 2024